Augmented ustekinumab dosing is needed to achieve clinical response in patients with anti-TNF refractory pediatric Crohn’s disease: a retrospective chart review

por Do, Phinga, Andersen, John, Patel, Ashish, Semrin, Gaith, Sifuentes-Dominguez, Luis, Luu, Phuong, Gurram, Bhaskar
Publicado 2021